NovImmune raised €6.0M in a Grant round in Oct 2012. The company is based in Plan-les-Ouates, Switzerland. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.0M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
